Daaco, Irine Kate .
HRN: 15-39-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
CEFUROXIME 750MG (VIAL)
11/27/2023
12/03/2023
IVT
500mg
Q8
Pneumonia, UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes